| abstract |
The present invention provides a self-renewing phenotypically homogeneous population of oligodendrocyte progenitor cells with synchronized developmental stages and a self-renewing phenotypically homogeneous population of oligodendrocyte progenitor cells The method is described. Other methods include a method for maintaining and preserving a homogeneous population of oligodendrocyte progenitor cells for a long time without changing the characteristics of the cells, and a method for dedifferentiating oligodendrocyte progenitor cells Is mentioned. A self-renewing phenotypically homogeneous population of oligodendrocyte progenitor cells or a homogeneous population of oligodendrocytes may be useful for treating patients with CNS disorders or CNS conditions. |